Film News

Samantha will take further treatment in South Korea

According to a recent story, Samantha Ruth Prabhu is purportedly traveling to South Korea to get treatment for myositis. The actress revealed in October that she had been diagnosed with myositis and had been receiving treatment for some time, but that her recovery had taken longer than she had anticipated. In contrast to earlier rumors that Samantha was seeking Ayurvedic medicine for her health, it is now said that she is looking to South Korea for care.

Samantha

Samantha Ruth Prabhu will travel to South Korea and stay there for several months to receive sophisticated medical care. Samantha aspires to get physically fit during her time in South Korea, according to the article, and she plans to soon return to the Kushi set, where she will be working alongside Vijay Deverakonda. These claims have not yet been addressed by Samantha and her team.

Samantha4550

An autoimmune condition called myositis occurs when the immune system assaults the muscles. One or more disorders that produce muscular inflammation are possible causes of the disease. While Samantha’s health was a concern for her admirers, the Yashoda actress reassured them that she is “not dying.”

A few days back in an interview, Samantha mentioned that even getting up from her bed was difficult for her on some days, and on some days, she is ready for a fight. She then addressed the reports claiming it was a life-threatening condition and issued a clarification. “I want to clarify that I am not dying anytime soon. I saw many articles that I have a life-threatening condition. No, I don’t. It’s an autoimmune condition. It’s draining and tiring. I’ve always been a fighter and I will fight,” she said.

 

View this post on Instagram

 

A post shared by Samantha (@samantharuthprabhuoffl)

Samantha’s last release was Yashoda. The Indian adaptation of Citadel, Kushi, and Shaakuntalam are upcoming projects for the actress.

Click to comment

You must be logged in to post a comment Login

Leave a Reply

Most Popular

To Top